Transcriptional and posttranscriptional regulation of erythroid gene expression in anthracycline-induced differentiation of human erythroleukemic cells

Cell Growth and Differentiation

Volumn 7, Issue 8, 1996, Pages 1023-1029

  Morceau, Franck ^a   Chénais, Benoît ^a   Gillet, Reynald ^a   Jardillier, Jean Claude ^a   Jeannesson, Pierre ^a   Trentesaux, Chantai ^a  

^a UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACLACINOMYCIN; ANTHRACYCLINE; DOXORUBICIN; ERYTHROPOIETIN RECEPTOR; PORPHOBILINOGEN;

ARTICLE; GENE EXPRESSION; GENE INDUCTION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HEME SYNTHESIS; HEMOGLOBINURIA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEIN SYNTHESIS; STEADY STATE; TRANSACTIVATION;

ACLARUBICIN; ANTHRACYCLINES; CELL DIFFERENTIATION; CELLS, CULTURED; DNA-BINDING PROTEINS; DOXORUBICIN; ERYTHROID PROGENITOR CELLS; ERYTHROID-SPECIFIC DNA-BINDING FACTORS; GATA1 TRANSCRIPTION FACTOR; GENE EXPRESSION; GLOBINS; HUMANS; HYDROXYMETHYLBILANE SYNTHASE; NUCLEAR PROTEINS; PROTEIN BIOSYNTHESIS; PROTEINS; RECEPTORS, ERYTHROPOIETIN; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, MESSENGER; TIME FACTORS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS;

EID: 0029845132     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Paquette, R. L., and Koeffler, H. P. Differentiation therapy. Hematol. Oncol. Clin. N. Am., 6: 687-706, 1992.
2. Beere, H. M., and Hickman, J. A. Differentiation: a suitable strategy for cancer chemotherapy? Anti-Cancer Drug Des., 8: 299-322, 1993.
3. Degos, L. Annual guest lecture, Leukemia Research Fund (UK): differentiation therapy and leukemia. Leukemia (Baltimore), 7: 766-772, 1993.
4. Breitman, T. R., Selonick, S. E., and Collins, S. J. Induction of differentiation of the human promyelocytic leukemia cell line (HL60) by retinoic acid. Proc. Natl. Acad. Sci. USA, 77: 2936-2940, 1980.
5. Castaigne, S., Chomienne, C., Daniel, M. T., Ballerini, P., Berger, R., Fenaux, P., and Degos, L. All-trans-retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood, 76: 1704-1709, 1990.
6. Chomienne, C., Ballerini, P., Balitrand, N., Daniel, M. T., Fenaux, P. Castaigne, S., and Degos, L. All-trans-retinoic acid in acute promyelocytic leukemia. II. In vitro studies. Blood, 76: 1710-1717, 1990.
7. Newmark, H. L., Lupton, J. R., and Young, C. W. Butyrate as a differentiating agent: pharmacokinetics, analogues and current status. Cancer Lett., 78: 1-5, 1994.
8. Casazza, A. M. Anthracyclines as inducers of tumor cell differentiation, In: J. W. Lown (ed.), Bioactive Molecules, Vol. 6, pp. 715-734. Amsterdam: Elsevier Science Publishers, B. V., 1988.
9. Gabbay, E. J., Grier, D., Fingerle, R. E., Reimer, R., Levy, R., Pearce, S. W., and Wilson, W. D. Interaction specificity of the anthracyclines with deoxyribonucleic acid. Biochemistry, 15: 2062-2069, 1976.
10. Potmesil, M. DNA topoisomerase II as intracellular target in anthracycline treatment of cancer, In: J. W. Lown (ed.), Anthracycline and Anthracenedione-based Anticancer Agents, pp. 447-466. Amsterdam: Elsevier Science Publishers, B. V., 1988.
11. Trentesaux, C., Gérard, B., Mayeux, P., Jeannesson, P., Jacquot, R., and Jardillier, J-C. Differentiating activity of Adriamycin in human erythroleukemic cells: effect on globin and heme synthesis, Biochim. Biophys. Acta, 1012: 161-165, 1989.
12. Jeannesson, P., Trentesaux, C., Ngo Nyoung, M., Mayeux, P., Jacquot, R., and Jardillier, J-C. Induction of erythropoietin receptors during aclacinomycin-mediated erythroid differentiation of K562 leukemia cells. Leukemia (Baltimore), 5: 14-18, 1991.
13. Morceau, F., Aries, A., Lahlil, R., Devy, L., Jardillier, J-C., Jeannesson, P., and Trentesaux, C. Evidence for distinct regulation processes in the aclacinomycin and doxorubicin-mediated differentiation of human erythroleukemic cells. Biochem. Pharmacol., 51: 839-845, 1996.
14. Weiss, J. W., and Orkin, S. H. GATA transcription factors: key regulators of hematopoiesis. Exp. Hematol., 23: 99-107, 1995.
15. Andrews, N. C., Erdjument-Bromage, H., Davidson, M. B., Tempst, P., and Orkin, S. H. Erythroid transcription factor NF-E2 is a haematopoietic-specific basic-leucine zipper protein. Nature (Lond.), 362: 722-728, 1993.
16. Orkin, S. H. Regulation of globin gene expression in erythroid cells. Eur. J. Biochem., 237: 271-281, 1995.
17. Zon, L. I., Youssoufian, H., Mather, C., Lodish, H. F., and Orkin, S. H. Activation of the erythropoietin receptor by transcription factor GATA-1. Proc. Natl. Acad. Sci. USA, 88: 10638-10641, 1994.
18. Mignotte, V., Eleouet, J-F., Raich, N., and Romeo P-H. Cis- and trans-acting elements involved in the regulation of the erythroid promoter of the human porphobilinogen deaminase gene. Proc. Natl. Acad. Sci. USA, 86: 6548-6552, 1989.
19. Tsai, S-F., Strauss, E., and Orkin, S. H. Functional analysis and in vivo footprinting implicate the erythroid transcription factor GATA-1 as a positive regulator of its own promoter. Genes Dev., 5: 919-931, 1991.
20. Pevny, L., Simon, L. C., Robertson, E., Klein, W. H., Tsai, S-F., d'Agati, V., Orkin, S. H., and Costantini, F. Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1. Nature (Lond.), 349: 257-260, 1991.
21. Andrews, N. C., Kotkow, K. J., Ney, P. A., Erdjument-Bromage, H., Tempst, P., and Orkin S. H. The ubiquitous subunit of erythroid transcription factor NF-E2 is as small basic-leucine zipper protein related to the v-maf oncogene. Proc. Natl. Acad. Sci. USA, 90: 11488-11492, 1993.
22. Ney, P. A., Sorrentino, B. P., Lowrey, C. H., and Nienhuis, A. W. Inducibility of the HSII enhancer depends on binding of an erythroid-specific nuclear protein. Nucleic Acids Res., 18: 6011-6017, 1990.
23. Trentesaux, C., Ngo Nyoung, M., Aries, A., Morceau, F., Ronchi, A., Ottolenghi, S., Jardillier, J-C., and Jeannesson P. Increased expression of GATA-1 and NFE-2 erythroid transcription factors during aclacinomycin-mediated differentiation of human erythroleukemic cells. Leukemia (Baltimore), 7: 452-457, 1993.
24. Brewer, G., and Ross, J. Regulation of c-myc RNA stability in vitro by a labile destabilizer with an essential nucleic acid component. Mol. Cell. Biol., 9: 1996-2006, 1989.
25. Ngo Nyoung, M., Trentesaux, C., Aries, A., Carpentier, Y., Jardillier, J-C., Gorisse, M-C., and Jeannesson, P. Effect of aclacinomycin-doxorubicin association on differentiation and growth of human erythroleukemic K562 cells. Anticancer Res., 14: 1203-1208, 1994.
26. Aries, A., Trentesaux, C., Ottolenghi, S., Jardillier, J-C., Jeannesson, P., and Doubeikovski, A. Activation of erythroid specific promoters during anthracycline-induced differentiation of K562 cells. Blood, 87: 2885-2890, 1996.
27. Bridges, E. G., Trentesaux, C., Lahlil, R., Spiga, M-G., Jeannesson, P., and Sommadossi, J-P. 3′-Azido-3′-deoxythymidine inhibits erythroid-specific transcription factors in human erythroid K562 leukemia cells. Eur. J. Haematol., 56: 62-67, 1996.
28. Merika, M., and Orkin, S. H. Functional synergy and physical interactions of the erythroid transcription factor GATA-1 with the Krüppel family proteins Sp1 and EKLF. Mol. Cell. Biol., 15: 2437-2447, 1995.
29. Kawana, M., Lee, M-E., Quertermous, E. E., and Quertermous, T. Cooperative interaction of GATA-2 and AP1 regulates transcription of the endothelin-1 gene. Mol. Cell. Biol., 15: 4225-4231, 1995.
30. Gong, Q., and Dean, A. Enhancer-dependent transcription of the ε-globin promoter requires promoter bound GATA-1 and enhancer-bound AP1/NF-E2. Mol. Cell. Biol., 13: 911-917, 1993.
31. Ross, J. mRNA stability in mammalian cells. Microbiol. Rev., 59: 423-450, 1995.
32. Lin, C-H., Palma, J. F., and Solomon, W. B. Phorbol ester induction of differentiation and apoptosis in the K562 cell line is accompanied by marked decreases in the stability of globin mRNAs and decreases in the steady state level of mRNAs encoding for ribosomal proteins L35, L31, L27, and L21. Cell. & Mol. Biol. Res., 40: 13-26, 1994.
33. Busfield, S. J., Spadaccini, A., Riches, K. J., Tilbrook, P. A., and Klinken, S. P. The major erythroid DNA-binding protein GATA-1 is stimulated by erythropoietin but not by chemical inducers of erythroid differentiation. Eur. J. Biochem., 230: 475-480, 1995.
34. Tsiftsoglou, A. S., and Wong, W. Molecular and cellular mechanisms of leukemic hemopoietic cell differentiation: an analysis of the Friend system. Anticancer Res., 5: 81-100, 1985.
35. Ponka, P., and Schulman, H. M. Regulation of heme biosynthesis: distinct regulatory features in erythroid cells. Stem Cells, 11: 24-35, 1993.
36. Profous-Juchelka, H. R., Reuben, R. C., Marks, P. A., and Rifkind, R. A. Transcriptional and post-transcriptional regulation of globin gene accumulation in murine erythroleukemia cells. Mol. Cell. Biol., 3: 229-232, 1983.
37. Charnay, P., and Maniatis T. Transcriptional regulation of globin gene synthesis expression in the human erythroid cell line K562. Science (Washington DC), 220: 1281-1283, 1983.
38. 3. Exp. Cell Res., 204: 241-246, 1993.
39. Morle, F., La Verriere, A. L., and Godet, J. Globin genes are actively transcribed in the human megakaryoblastic leukemia cell line MEG-01. Blood, 79: 3094-3095, 1992.